Regions Financial Corp’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-1,985
| Closed | -$245K | – | 807 |
|
2020
Q2 | $245K | Sell |
1,985
-429
| -18% | -$53K | ﹤0.01% | 696 |
|
2020
Q1 | $204K | Sell |
2,414
-186
| -7% | -$15.7K | ﹤0.01% | 716 |
|
2019
Q4 | $220K | Buy |
+2,600
| New | +$220K | ﹤0.01% | 763 |
|
2019
Q3 | – | Sell |
-2,870
| Closed | -$246K | – | 815 |
|
2019
Q2 | $246K | Sell |
2,870
-137
| -5% | -$11.7K | ﹤0.01% | 721 |
|
2019
Q1 | $267K | Buy |
3,007
+453
| +18% | +$40.2K | ﹤0.01% | 698 |
|
2018
Q4 | $217K | Sell |
2,554
-108
| -4% | -$9.18K | ﹤0.01% | 742 |
|
2018
Q3 | $258K | Buy |
2,662
+324
| +14% | +$31.4K | ﹤0.01% | 758 |
|
2018
Q2 | $221K | Buy |
2,338
+41
| +2% | +$3.88K | ﹤0.01% | 791 |
|
2018
Q1 | $187K | Hold |
2,297
| – | – | ﹤0.01% | 853 |
|
2017
Q4 | $205K | Sell |
2,297
-27
| -1% | -$2.41K | ﹤0.01% | 842 |
|
2017
Q3 | $216K | Buy |
+2,324
| New | +$216K | ﹤0.01% | 821 |
|
2014
Q4 | – | Sell |
-23,500
| Closed | -$1.7M | – | 943 |
|
2014
Q3 | $1.7M | Sell |
23,500
-1,675
| -7% | -$121K | 0.02% | 401 |
|
2014
Q2 | $1.57M | Buy |
25,175
+6,125
| +32% | +$381K | 0.02% | 459 |
|
2014
Q1 | $1.3M | Sell |
19,050
-1,000
| -5% | -$68.2K | 0.02% | 506 |
|
2013
Q4 | $1.41M | Sell |
20,050
-890
| -4% | -$62.6K | 0.02% | 453 |
|
2013
Q3 | $1.51M | Sell |
20,940
-4,200
| -17% | -$303K | 0.02% | 390 |
|
2013
Q2 | $1.4M | Buy |
+25,140
| New | +$1.4M | 0.02% | 381 |
|